ABC01097SB

Pioglitazone metabolite MIV

Pioglitazone metabolite MIV is a thiazolidinedione derivative, featuring a thiazole ring and a hydroxylated pyridine moiety. Its structure is characterized by the presence of a chiral center and a sulfonamide functional group. As a primary metabolite of Pioglitazone, it retains the core thiazolidinedione scaffold. This compound serves as a critical HPLC reference standard.

On Request
Molecular Formula C19H20N2O4S
Molecular Weight 372.4000
CAS Number 146062-44-4 ✓ Verified
PubChem CID 4147757 ↗
Purity N/A
Product Type API Impurity
Parent Drug Pioglitazone
Lead Time On Request
IUPAC Name 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

📝 Synonyms

Hydroxypioglitazone 146062-44-4 Leriglitazone MIN-102 Leriglitazona K824X25AYA 2,4-Thiazolidinedione, 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]- CHEBI:82937 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione DTXSID30399914

🔬 Chemical Identifiers

CC(C1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3)O
InChI=1S/C19H20N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7,11-12,17,22H,8-10H2,1H3,(H,21,23,24)
OXVFDZYQLGRLCD-UHFFFAOYSA-N

Related Products